Air Liquide has acquired French start-up company EOVE to reinforce its expertise in home ventilation for chronic respiratory failure.
EOVE specialises in the design and manufacture of ventilators for home-based patients suffering from chronic respiratory failure. It has developed an innovative solution: a connected portable ventilator that takes into account the mobility needs of patients and facilitates the practice of doctors.
Founded in 2014, EOVE has developed an Android-based technology platform. The company’s ventilator offers advanced features for mobility, combining a compact size and connectivity. It enables the implementation of all therapeutic strategies. This offer, already available in France, Italy, Germany, South Korea, and Canada, is geared for patients who suffer from neuromuscular diseases and who need continuous ventilation. In 2017, EOVE generated total revenue of nearly €5m.
The acquisition of EOVE enables Air Liquide to reinforce its expertise in home ventilation for chronic respiratory failure thanks to cutting-edge technological know-how and a team dedicated to innovation specialised in the life support ventilation segment, the Tier One company explained in a press release. This will also enable EOVE to accelerate its international development.
François Jackow, member of the Air Liquide Group’s Executive Committee, supervising Healthcare activities, said, “EOVE is recognised for its know-how and capacity for innovation in home ventilation, as well as for the expertise of its teams. This acquisition enables Air Liquide to extend its service offering in the area of respiratory diseases through a unique connected solution. As such, it is completely in line with our home healthcare development strategy.”